Showing results (31-40 of 224) with videos related to

Sort By:
Pageof 23
Therapeutic Drug Monitoring|January 28, 2003
High-performance liquid chromatographic analysis of the anticancer drug irinotecan (CPT-11) and its active metabolite SN-38 in human plasmaNadja E Schoemaker, Hilde Rosing, Sindy Jansen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 11, 2022
Optimized sample pre-treatment procedure for the simultaneous UPLC-MS/MS quantification of ipilimumab, nivolumab, and pembrolizumab in human serumKaren A M de Jong, Hilde Rosing, Alwin D R Huitema, et al.
Biomedical Chromatography : BMC|July 27, 2004
A more sensitive MS detector does not obviously lead to a more sensitive assay: experiences with ES-285Ellen Stokvis, Hilde Rosing, Luis López-Lázaro, et al.
Therapeutic Drug Monitoring|May 29, 2025
Stabilization of Abiraterone in Human Plasma Using the Esterase Inhibitor Bis(4-nitrophenyl) PhosphateMaaike A C Bruin, Luc Lucas, Jos H Beijnen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 9, 2007
Simultaneous quantification of cyclophosphamide and its active metabolite 4-hydroxycyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (LC-MS/MS)Corine Ekhart, Abadi Gebretensae, Hilde Rosing, et al.
Anti-Cancer Drugs|June 3, 2016
Cytosine arabinoside and daunorubicin induction therapy in a patient with acute myeloid leukemia on chronic hemodialysisEilon Krashin, Osnat J Dolberg, Ilana Hellmann, et al.
Biomedical Chromatography : BMC|January 8, 2026
An Overview of Liquid Chromatography-Mass Spectrometry (LC-MS) Methods for the Quantification of Antibody-Drug ConjugatesPauline L M Buitelaar, Hilde Rosing, Jos H Beijnen, et al.
Pageof 23